P. Lagadec et al., Evidence for control of nitric oxide synthesis by intracellular transforming growth factor-beta 1 in tumor cells - Implications for tumor development, AM J PATH, 154(6), 1999, pp. 1867-1876
Citations number
41
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Medical Research Diagnosis & Treatment
Transforming growth factor-beta 1 (TGF-beta 1) has been shown to down-regul
ate NO synthesis in a variety of normal cells. In the present study, we inv
estigated the influence of TGF-beta 1 upon NO production in tumor cells and
its consequences for tumor development. During the growth of PROb colon ca
rcinoma cells intraperitoneally injected in syngeneic BDM rats, intratumora
l concentration of TGF-beta 1 increases while NO concentration stays very l
ow. Tumor regression induced by intraperitoneal injections of a lipid A is
associated with a decrease in TGF-beta 1 and an increase in NO intratumoral
concentration. In these tumors, PROb tumor cells are the NO- and TGF-beta
1-secreting cells. Using PROb cells transfected with an expression vector c
oding for TGF-beta 1 antisense mRNA, we demonstrate in vitro that there is
an inverse correlation between the amount of TGF-beta 1 secreted and the ab
ility of PROb cells to secrete NO. As the same results were obtained in the
presence of an anti-TGF-beta type II receptor neutralizing antibody, and a
s exogenous TGF-beta 1 is without any effect on NO secretion by PROb cells,
TGF-beta 1 apparently down-regulates NO synthesis in PROb cells by an intr
acellular mechanism. These results suggest that endogenous TGF-beta 1 const
itutes a potential target in a search for new antitumoral agents.